US SB4378 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on June 13 2022 - 25% progression, died in committee
Action: 2022-06-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 13 2022 - 25% progression, died in committee
Action: 2022-06-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to reauthorize a provision of the Federal Food, Drug, and Cosmetic Act pertaining to drugs containing single enantiomers.
Title
Hatch-Waxman Improvement Act of 2022
Sponsors
| Sen. Roger Marshall [R-KS] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-06-13 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
SB4348 (Related) 2022-07-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/4378/all-info |
| Text | https://www.congress.gov/117/bills/s4378/BILLS-117s4378is.pdf |
